|
|
 |
|
Viewing report
|
|
|
|
Human Reproductive Technologies - Global Strategic Business Report
Global Industry Analysts, Inc, Oct 2006, Pages: 496
This report analyzes the worldwide markets for Human Reproductive Technologies in US$ Million. The major product segments analyzed are Fertility Enhancement Drugs, Fertility Technologies & Procedures, Contraceptives & Abortion (Oral Contraceptives, Condoms, and Implants/ Injections), and Reproduction-Assisted Diagnostics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 100 companies including many key and niche players worldwide such as Ardana Limited, ICOS Corp, Serono S.A., Vivus, Inc., Akzo Nobel, Organon Inc., Barr Pharmaceuticals, Inc., Church & Dwight Co., Inc., Conceptus Inc., Female Health Company, Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc., Okamoto Industries Inc., Pfizer Inc., Schering AG, Watson Pharmaceuticals, Inc., Wyeth Corporation, Adeza Biomedical Corporation, Inverness Medical Innovations Ltd, Repromedix Corp, and Repros Therapeutics Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on 'Enquire before buying'
|
|
|
|
